Dr. Samer Ibrahim Renno, MD

  • Columbus, NE
  • Hematologist and oncologist
NPI1588758312PAC ID9335181767
Medicare services, 2024
303,504
Medicare patients, 2024
1,095
Part D claims, 2024
2,264
Clinical trials
1
Hospital affiliations
5
Practice address
4508 38th St, Columbus, NE 68601
Practice phone
Call (402) 572-3535
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Hematology & Oncology Consultants

Columbus, Nebraska

See all 8 affiliations

Find Dr. Renno's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Samer Ibrahim Renno is a hematologist and oncologist in Columbus, Nebraska

Dr. Renno practices at Hematology & Oncology Consultants in Columbus, Nebraska.

Dr. Renno's NPI, 1588758312, was assigned on October 3, 2006. Dr. Renno holds Nebraska license 22157.

NPI and contact details
Medicare PAC ID
9335181767
NPI enumeration date
October 3, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(402) 572-3535
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
56
Medical school graduation
1996

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Samer Ibrahim Renno practices at Hematology & Oncology Consultants in Columbus, Nebraska

Dr. Renno's primary practice is Hematology & Oncology Consultants, at 4508 38th St, Columbus, NE 68601 in Platte County. The practice phone is (402) 572-3535.

  • Hematology & Oncology Consultants
    4508 38th St, Columbus, NE 68601 · Platte CountyPhone(402) 572-3535

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Samer Ibrahim Renno is affiliated with 6 sites of care and 2 medical groups

Dr. Renno's primary practice is Hematology & Oncology Consultants in Columbus, Nebraska. Dr. Renno is also affiliated with Columbus Community Hospital. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Renno to 4 more hospitals and 1 medical group, each named with a free account.

See all 8 affiliations for Dr. Renno

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Samer Ibrahim Renno's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renno practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Hematology & Oncology ConsultantsAvailable with a free account
+5 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Renno practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Samer Ibrahim Renno is one of 80 hematologists and oncologists in Nebraska

Hematology and oncology is Dr. Renno's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Renno's licenses on file in 2 states: Nebraska and Iowa.

Specialties and state licenses

  • Hematology and oncology, NebraskaPrimaryLicense 22157 · taxonomy 207RH0003X
  • Iowa licenseLicense 32052

Hematologists and oncologists near Dr. Renno

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Samer Ibrahim Renno billed Medicare for 303,504 services in 2024

CMS data shows 303,504 Medicare services from Dr. Renno across 59 procedure codes in 2024, for 1,095 Medicare patients. Medicare paid $4,277,705 for them.

Medicare services, 2024303,504
Medicare patients1,095
Paid by Medicare$4.3M
Procedure codes59

Dr. Renno's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 252,4592024: 242,7014%
Other services
2023: 10,3802024: 52,868409%
Tests and treatments
2023: 4,5052024: 4,8798%
Office and hospital visits
2023: 2,0842024: 2,1845%
Lab and pathology
2023: 4712024: 4863%
Surgery
2023: 3412024: 38613%

Where Dr. Renno's Medicare services took place, 2024

  • In an office303,480100%
  • In a facility240%

Dr. Renno compared with the Nebraska median for hematologists and oncologists, 2024

  • Dr. Renno
  • Nebraska median
Medicare services
303,504vs 1,322229.6 times
Medicare patients
1,095vs 4082.7 times
Part D claims
1,932vs 5493.5 times

Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.

Dr. Renno's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Renno

Need commercial claims for Dr. Renno?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Renno and other hematologists and oncologists in Nebraska.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Samer Ibrahim Renno treated 1,095 Medicare patients in 2024, average age 75

CMS counts 1,095 Medicare patients who saw Dr. Renno in 2024. The largest group is 65 to 74, with 474 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Renno's median patient age at 71, with 59% women.

Medicare patients, 20241,095
Average age75
Average risk score1.93
Also on Medicaid9%

Dr. Renno's Medicare patients by age, 2024

Dr. Renno's Medicare patients by sex, 2024

  • Women66060%
  • Men43540%

Chronic conditions among Dr. Renno's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol74%
  3. Arthritis46%
  4. Cancer45%
  5. Chronic kidney disease38%
  6. Diabetes30%
  7. Ischemic heart disease29%
  8. Mood disorders26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Renno's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women59%
  • Men40%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Samer Ibrahim Renno wrote 2,264 Medicare Part D claims in 2024

In 2024, Dr. Renno wrote 2,264 Medicare Part D claims for 382 patients. 81% of them were for generic drugs. CMS names the drug for 1,932 of them, across 50 drugs with 11 or more claims each, at $2,248,001 in total drug cost. In 2023, CMS named 1,649 claims across 41 drugs.

Part D claims, 20242,264
Drugs named by CMS50
Total drug cost$2.2M
Part D patients382

Dr. Renno's Part D claims by kind of drug, 2024

  • Generic1,838 claims81%
  • Brand-name and other426 claims19%

Dr. Renno's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Renno's Part D claims, 2024

  • Opioids5%116 of 2,264 claims
  • Antibiotics3%60 of 2,264 claims
  • Antipsychotics, patients 65 and over1%32 of 2,264 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6492024: 1,93217%

Drugs named by CMS: 50 in 2024, 41 in 2023.

See all prescribing by Dr. Renno

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Samer Ibrahim Renno takes part in Medicare

Dr. Renno accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Renno by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Samer Ibrahim Renno has worked on 1 clinical trial

Dmand AI links Dr. Renno to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

Conditions in Dr. Renno's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic

Investigators on the most trials with Dr. Renno

Recent clinical trials with Dr. Renno

Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Samer Ibrahim Renno received $82,472 in industry payments from 2016 to 2025

CMS Open Payments shows 286 general payments to Dr. Renno from 39 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. AstraZeneca Pharmaceuticals LP paid the most, $25,131.

General payments to Dr. Renno by program year, 2016 to 2025

General payments to Dr. Renno by kind, 2016 to 2025

$82.5Kin total
  • Consulting fees$54,20866%
  • Travel and lodging$11,84514%
  • Speaker and faculty fees$6,1257%
  • Food and beverage$5,3727%
  • Other$4,9226%

Companies that paid Dr. Renno the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Renno

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Samer Ibrahim Renno's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Samer Ibrahim Renno

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Samer Ibrahim Renno's NPI number?

Dr. Samer Ibrahim Renno's NPI number is 1588758312. It was assigned on October 3, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Samer Ibrahim Renno?

Dr. Samer Ibrahim Renno is a hematologist and oncologist in Columbus, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Samer Ibrahim Renno practice?

Dr. Renno practices at 4508 38th St, Columbus, NE 68601. Dr. Renno's primary practice is Hematology & Oncology Consultants in Columbus, Nebraska. Dmand AI also links Dr. Renno to 4 hospitals and 1 medical group.

What is Dr. Samer Ibrahim Renno's office phone number?

The practice phone on file for Dr. Renno is (402) 572-3535.

What is Dr. Samer Ibrahim Renno's medical license number?

Dr. Renno holds Nebraska license 22157, one of the licenses on file in 2 states.

Which states has Dr. Samer Ibrahim Renno been licensed in?

Dmand AI has state licenses on file for Dr. Renno in Nebraska and Iowa.

Which hospitals is Dr. Samer Ibrahim Renno affiliated with?

Dr. Renno is affiliated with Columbus Community Hospital. Dmand AI links Dr. Renno to 4 more hospitals.

What medical group is Dr. Samer Ibrahim Renno part of?

Dr. Renno is linked to CHI Health Clinic. Dmand AI links Dr. Renno to 1 more medical group.

Does Dr. Samer Ibrahim Renno accept Medicare?

Yes. CMS data shows Dr. Renno billed Medicare for 303,504 services in 2024, and Dr. Renno accepts Medicare assignment.

How many Medicare patients does Dr. Samer Ibrahim Renno see?

CMS counts 1,095 Medicare patients who saw Dr. Renno in 2024, with an average age of 75.

Show 5 more questionsShow fewer questions

What services does Dr. Samer Ibrahim Renno bill to Medicare?

In 2024, Dr. Renno's most billed Medicare services were injected or infused drug (J0881), medicare temporary code (Q5125) and injected or infused drug (J9271).

What drugs does Dr. Samer Ibrahim Renno prescribe most?

In 2024 Medicare Part D data, Dr. Renno's most prescribed drugs by claims were Anastrozole, Tamoxifen Citrate and Potassium Chloride.

Has Dr. Samer Ibrahim Renno received payments from drug or device companies?

CMS Open Payments shows $82,472 in general payments to Dr. Renno from 39 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Samer Ibrahim Renno been practicing?

Dr. Renno graduated from medical school in 1996, 30 years ago.

Does Dr. Samer Ibrahim Renno do research?

Dr. Renno has worked on 1 clinical trial.

Selling to hematology and oncology practices?

See hematologists and oncologists in Nebraska by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)